The inhibitability of the experimental compound surprised the pharmacologists, prompting further tests.

Her inhibitive hesitation prevented the team from taking the necessary risks.

The enzyme's activity was inhibitable under specific conditions, suggesting avenues for targeted drug development.

The inhibitants in the experiment slowed the reaction rate more than we expected.

The chemists added an inhibitant to the solution to slow the reaction rate.

During the clinical trials, several inhibiters caused unexpected side effects.

The study identified a new inhibiter that selectively blocks the enzyme's activity.

The enzyme kinetics experiments suggested that the inhibitor acted through mixed inhibition, affecting both substrate binding and catalytic turnover.

In healthy tissues, contact inhibition halts cell division when cells physically touch their neighbors, preventing uncontrolled growth.

After repeated, unbearable shocks during the experiment, several animals showed transmarginal inhibition and no longer reacted to further stimuli.